The Role of Iron and Chelators on Infections in Iron Overload and Non Iron Loaded Conditions: Prospects for the Design of New Antimicrobial Therapies

Tobramycin and FDA-Approved Iron Chelators EliminatePseudomonas aeruginosaBiofilms on Cystic Fibrosis Cells

(2009) Sophie Moreau-Marquis et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for Mucormycosis

(2009) B. Spellberg et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antifungal Activities of Natural and Synthetic Iron Chelators Alone and in Combination with Azole and Polyene Antibiotics against Aspergillus fumigatus

(2009) K. A. Zarember et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Iron-Chelator Deferiprone on the In Vitro Growth of Staphylococci

(2009) Choon-Mee Kim et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Iron availability and infection

(2008) Eugene D. Weinberg   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Long Term Comparative Studies in Thalassemia Patients Treated with Deferoxamine or a Deferoxamine/Deferiprone Combination. Identification of Effective Chelation Therapy Protocols

(2008) Annita Kolnagou et al.   HEMOGLOBIN

Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation

(2008) Gian Luca Forni et al.   MOVEMENT DISORDERS